DEVELOPMENT AND PRECLINICAL EVALUATION OF A NOVEL TARGETED RADIONUCLIDE THERAPY FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER.

Purdue University, West Lafayette IN

Investigators